A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury.
Ambrish SinghSalman HussainVijay KherAndrew J PalmerMatthew JoseBenny AntonyPublished in: Expert review of pharmacoeconomics & outcomes research (2021)
CEAs of RRTs for AKI show conflicting findings with secular trends. Latest CEAs suggested CRRT to be cost-effective versus IRRT with dialysis dependence rate as major driver of cost-effectiveness. Future CEAs, preferably non-industry sponsored, may account for indirect costs to improve the generalizability of CEAs.